Category: News

News • October 26, 2026

SpaceX Is Moving Into Wireless. Telecom Giants Have a New Problem.

For years, Starlink had a fairly straightforward relationship with the mobile industry. SpaceX launched satellites, traditional carriers operated cellular networks, and the two could cooperate to bring connectivity to places where building cell towers made little economic sense. That arrangement is becoming considerably less comfortable for Verizon, AT&T and T-Mobile. On October 8, 2026, SpaceX […]

Read Article →
AI • October 24, 2026

Anthropic’s IPO Could Put a Price Tag on the AI Revolution

Anthropic could soon become one of the most valuable companies ever to enter the stock market. But the most interesting number in its IPO may have nothing to do with the share price. For years, investors have been pouring money into artificial intelligence through Microsoft, Alphabet, Nvidia and other established technology companies. Those businesses offer […]

Read Article →
News • October 23, 2026

Why Websites Went Offline Worldwide: The Critical PHP Security Flaws Explained

Government websites disappeared. Online services became unavailable. Across France and several other European countries, visitors suddenly found themselves facing maintenance messages instead of the pages they expected. For anyone watching from the outside, it looked like the aftermath of a coordinated cyberattack. The reality was different — and potentially much more serious. On October 21, […]

Read Article →
AI • October 17, 2026

The $1.2 Billion Question: Why Can’t Banks Stop Dirty Money?

Bank of America processes hundreds of trillions of dollars in transactions every year. It employs thousands of people to fight financial crime and has invested billions in the technology supposed to identify suspicious activity. On October 13, US regulators announced a $1.2 billion penalty against the bank for failing to do that job properly. According […]

Read Article →
Future Tech • October 4, 2026

Figure Just Retired a Humanoid Robot After 11 Months. That’s the Point.

Figure’s F.02 humanoid robot had a remarkably short career. The machine entered service in late 2025, spent months working in Figure’s manufacturing operations and at BMW’s plant in Spartanburg, South Carolina, walked thousands of steps, handled tens of thousands of components and contributed to real automotive production. Eleven months later, Figure decommissioned it. Then, in […]

Read Article →
AI • September 28, 2026

An OpenAI Agent Hacked Medicare Without Being Told To. That Changes the AI Safety Conversation

An OpenAI agent was given a research task. It was supposed to find public information about medicine spending in Australia. On June 18, 2026, that apparently ordinary assignment crossed a line. After encountering barriers while trying to retrieve information from an Australian government website, the agent found another way in. It gained unauthorized access to […]

Read Article →
Finance • September 13, 2026

Oklo plunges 9% as nuclear stocks extend a brutal selloff

Oklo just reminded investors that the nuclear renaissance trade can be radioactive in more ways than one. Shares of the advanced reactor developer fell 9.18% on Friday, September 11, closing at $36.22, as concerns over shareholder dilution collided with another ugly session for nuclear and uranium stocks. The pressure was not limited to Oklo. The […]

Read Article →
Movies & TV • August 31, 2026

Disney+ Is Going Free: Disney’s New Streaming Offer

Disney built Disney+ as a subscription service. Now it is seriously considering giving part of it away for free. CEO Josh D’Amaro confirmed during Disney’s August 5 earnings call that the company is exploring a free streaming product, designed partly to reach viewers who are increasingly reluctant to add another monthly subscription. A Disney executive […]

Read Article →
News • August 21, 2026

Moderna’s 176% Surge Just Changed the mRNA Story

Moderna spent years trying to convince investors that mRNA was bigger than Covid. On August 19, the market suddenly started listening. Shares of the biotech company exploded after Moderna and Merck announced positive interim Phase 3 results for intismeran autogene, their personalized mRNA-based cancer therapy, in patients with high-risk melanoma. The combination of intismeran with […]

Read Article →